A Phase II/III trial of GMA102 for treatment of type 2 diabetes.
Latest Information Update: 12 Jan 2017
At a glance
- Drugs Glutazumab (Primary)
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Gmax Biopharm
- 12 Jan 2017 New trial record